Metabolic markers in blood can separate prostate cancer from benign prostatic hyperplasia.
Giskeødegård GF, Hansen AF, Bertilsson H, Gonzalez SV, Kristiansen KA, Bruheim P, Mjøs SA, Angelsen A, Bathen TF, Tessem MB.
Giskeødegård GF, et al. Among authors: bertilsson h.
Br J Cancer. 2015 Dec 22;113(12):1712-9. doi: 10.1038/bjc.2015.411. Epub 2015 Dec 3.
Br J Cancer. 2015.
PMID: 26633561
Free PMC article.